Literature DB >> 15496394

Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates.

Rosanna Mundy1, Claire Jenkins1, Jun Yu1, Henry Smith1, Gad Frankel1.   

Abstract

Enterohaemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli are important diarrhoeagenic pathogens; infection is dependent on translocation of a number of type III effector proteins. Until recently all the known effectors were encoded on the LEE pathogenicity island, which also encodes the adhesin intimin and the type III secretion apparatus. Recently, a novel non-LEE effector protein, EspI/NleA, which is required for full virulence in vivo and is encoded on a prophage, was identified. The aim of this study was to determine the distribution of espI among clinical EHEC and EPEC isolates. espI was detected in 86 % and 53 % of LEE+ EHEC and EPEC strains, respectively. Moreover, the espI gene was more commonly found in patients suffering from a more severe disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496394     DOI: 10.1099/jmm.0.45684-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  22 in total

1.  Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE.

Authors:  Jacqueline Njoroge; Vanessa Sperandio
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 3.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein.

Authors:  Kristina Creuzburg; Jürgen Recktenwald; Volker Kuhle; Sylvia Herold; Michael Hensel; Herbert Schmidt
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  SOS regulation of the type III secretion system of enteropathogenic Escherichia coli.

Authors:  Jay L Mellies; Kenneth R Haack; Derek C Galligan
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

6.  QseA directly activates transcription of LEE1 in enterohemorrhagic Escherichia coli.

Authors:  Faith C Sharp; Vanessa Sperandio
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

7.  The bacterial virulence factor NleA's involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain.

Authors:  Ajitha Thanabalasuriar; Athanasia Koutsouris; Gail Hecht; Samantha Gruenheid
Journal:  Gut Microbes       Date:  2010-03-03

8.  Genetic and Mechanistic Analyses of the Periplasmic Domain of the Enterohemorrhagic Escherichia coli QseC Histidine Sensor Kinase.

Authors:  Christopher T Parker; Regan Russell; Jacqueline W Njoroge; Angel G Jimenez; Ron Taussig; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2017-03-28       Impact factor: 3.490

9.  Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli.

Authors:  Wenting Ju; Jinling Shen; Magaly Toro; Shaohua Zhao; Jianghong Meng
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

10.  The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.

Authors:  Ajitha Thanabalasuriar; Athanasia Koutsouris; Andrew Weflen; Mark Mimee; Gail Hecht; Samantha Gruenheid
Journal:  Cell Microbiol       Date:  2009-08-27       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.